Drugs / Sennoside A+B
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06580366 Comparator | Aug → Dec 2024 overdue | — | Hitit University | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sennoside A+B | “What is Sennoside A+B? Sennoside A+B is a type of laxative made from the senna plant.” NCT06580366 ↗ |
| Modality | Small molecule | — CHEMBL1644069 ↗ |
| Route | Oral | “Participants were randomized 1:1 to receive either sennoside A + B oral solution (split-dose: 250 mL at 21:00 and 250 mL at 23:00)” PMID 42135569 ↗ May 2026 |